RELATED PARTY TRANSACTIONS (Details Narrative) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Oct. 26, 2022
USD ($)
|
Oct. 26, 2022
AUD ($)
|
Aug. 02, 2022
USD ($)
|
Aug. 02, 2022
AUD ($)
|
Aug. 02, 2022
USD ($)
|
Aug. 02, 2022
AUD ($)
|
May 04, 2022
USD ($)
|
May 04, 2022
AUD ($)
|
Aug. 12, 2021
USD ($)
shares
|
Jul. 13, 2020
AUD ($)
|
May 14, 2019
USD ($)
$ / shares
shares
|
May 14, 2019
AUD ($)
shares
|
Mar. 16, 2018
USD ($)
|
Mar. 16, 2018
AUD ($)
|
Feb. 01, 2018
USD ($)
|
Feb. 01, 2018
AUD ($)
|
Feb. 25, 2016
USD ($)
|
Feb. 25, 2016
AUD ($)
|
Feb. 25, 2015
AUD ($)
|
May 31, 2019
shares
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
Sep. 30, 2022
AUD ($)
shares
|
Sep. 30, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
|
Jun. 30, 2022
AUD ($)
|
Jun. 30, 2021
USD ($)
shares
|
Jun. 30, 2021
AUD ($)
shares
|
Jun. 30, 2020
USD ($)
|
Jun. 30, 2020
AUD ($)
|
Jun. 30, 2019
USD ($)
|
Jun. 30, 2019
AUD ($)
|
Sep. 30, 2022
AUD ($)
|
Jun. 30, 2022
AUD ($)
|
|
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Due to related parties | $ | $ 28,599 | $ 30,746 | |||||||||||||||||||||||||||||||
| Payments for rent | $ | 6,373 | $ 7,736 | |||||||||||||||||||||||||||||||
| Bonus payable | $ 26,620 | $ 41,387 | 99,691 | $ 144,166 | |||||||||||||||||||||||||||||
| Exercise price | $ / shares | |||||||||||||||||||||||||||||||||
| Granted exercise price | $ / shares | |||||||||||||||||||||||||||||||||
| Accrued salaries | $ 43,416 | 37,341 | $ 67,500 | $ 54,000 | |||||||||||||||||||||||||||||
| Chief Executive Officer [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Payments form related party | $ 221,890 | $ 136,606 | $ 202,620 | $ 64,377 | $ 90,000 | ||||||||||||||||||||||||||||
| Bonus payable amount | 137,120 | 200,000 | |||||||||||||||||||||||||||||||
| Remaining bonus amount | $ 90,007 | 139,937 | 125,386 | 181,324 | $ 178,256 | $ 260,000 | |||||||||||||||||||||||||||
| Bonus payable | $ 166,418 | $ 422,610 | $ 280,726 | $ 407,380 | |||||||||||||||||||||||||||||
| Restricted stock shares of common stock | 78 | ||||||||||||||||||||||||||||||||
| Nathanielsz Employment Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Expired date | Feb. 25, 2019 | ||||||||||||||||||||||||||||||||
| Annual salary | $ 25,000 | $ 300,000 | 205,680 | ||||||||||||||||||||||||||||||
| Percentage of pension of monthly salary | 9.50% | 9.50% | |||||||||||||||||||||||||||||||
| Percentage of bonus of annual base salary | 200.00% | 200.00% | |||||||||||||||||||||||||||||||
| Nathanielsz Employment Agreement [Member] | Subsequent Event [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ 414,900 | $ 600,000 | |||||||||||||||||||||||||||||||
| Nathanielsz Employment Agreement [Member] | Maximum [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ 414,900 | $ 600,000 | $ 274,240 | $ 400,000 | |||||||||||||||||||||||||||||
| Percentage of bonus of annual base salary | 200.00% | 100.00% | 100.00% | ||||||||||||||||||||||||||||||
| Nathanielsz Employment Agreement [Member] | Minimum [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ 276,600 | $ 400,000 | $ 205,680 | $ 300,000 | |||||||||||||||||||||||||||||
| Mrs. Nathanielsz [Member] | Chief Executive Officer [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Bonus payable | $ | $ 316,957 | ||||||||||||||||||||||||||||||||
| Employment Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock unit shares upon vest | 39 | 39 | |||||||||||||||||||||||||||||||
| Employment Agreement [Member] | Initial Nathanielsz RSUs [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock shares of common stock | 39 | 39 | |||||||||||||||||||||||||||||||
| Employment Agreement [Member] | Additional Nathanielsz RSUs [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock unit issuable | 39 | 39 | |||||||||||||||||||||||||||||||
| Employment Agreement [Member] | Additional Nathanielsz RSUs [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Grand date fair value, per share | $ / shares | $ 7.80 | ||||||||||||||||||||||||||||||||
| Gross proceeds from equity financing | $ | $ 4,000,000 | ||||||||||||||||||||||||||||||||
| Services Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock unit issuable | 20 | 20 | |||||||||||||||||||||||||||||||
| Services Agreement [Member] | Initial Kenyon RSUs [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock shares of common stock | 20 | 20 | |||||||||||||||||||||||||||||||
| Services Agreement [Member] | Additional Kenyon RSUs [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Restricted stock shares of common stock | 20 | 20 | |||||||||||||||||||||||||||||||
| Gross proceeds from equity financing | $ | $ 4,000,000 | ||||||||||||||||||||||||||||||||
| Restricted stock unit shares upon vest | 5 | 5 | |||||||||||||||||||||||||||||||
| North Horizon Pty Ltd [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Lessor, Operating lease, term of contract | 3 years | 3 years | |||||||||||||||||||||||||||||||
| Operating leases rent expense, minimum rentals | $ 2,176 | $ 3,000 | |||||||||||||||||||||||||||||||
| Former Director [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Loans from related party | $ | $ 28,599 | 30,746 | |||||||||||||||||||||||||||||||
| Due to related parties | $ | 47,597 | 51,171 | |||||||||||||||||||||||||||||||
| Nathanielsz [Member] | North Horizon Pty Ltd [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Operating leases, future minimum payments due | $ 84,342 | 84,452 | $ 131,129 | $ 122,129 | |||||||||||||||||||||||||||||
| Mrs. Nathanielsz [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ 80,904 | $ 120,000 | |||||||||||||||||||||||||||||||
| Payments form related party | $ 5,577 | $ 7,689 | |||||||||||||||||||||||||||||||
| James Nathanielsz [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Payments form related party | $ 3,205 | $ 4,481 | |||||||||||||||||||||||||||||||
| Mr. Nathanielsz [Member] | Board of Directors [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Officers compensation | $ 96,810 | $ 140,000 | $ 177,840 | $ 240,000 | $ 315,376 | $ 460,000 | |||||||||||||||||||||||||||
| Debt conversion, converted instrument, shares issued | 5,928,000 | ||||||||||||||||||||||||||||||||
| Mr. Nathanielsz [Member] | Board of Directors [Member] | AUD Currency [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Bonus granted percentage | 60.00% | ||||||||||||||||||||||||||||||||
| Mr. Nathanielsz [Member] | Employment Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ | $ 400,000 | ||||||||||||||||||||||||||||||||
| Agreement term | 3 years | 3 years | |||||||||||||||||||||||||||||||
| Agreement renewal term | 1 year | 1 year | |||||||||||||||||||||||||||||||
| Option purchase shares | 39 | 39 | |||||||||||||||||||||||||||||||
| Exercise price | $ / shares | $ 4,675 | ||||||||||||||||||||||||||||||||
| Market price | 110.00% | 110.00% | |||||||||||||||||||||||||||||||
| Granted exercise price | $ / shares | $ 4,250 | ||||||||||||||||||||||||||||||||
| Options vested, description | The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz’s continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz’s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the “CTA”) for PRP, the Company’s lead product candidate (“PRP”), for a First-In-Human study for PRP (the “Study”) in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company’s Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. | The Nathanielsz Options have a term of 10 years from the date of grant. 1/3rd of the Nathanielsz Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Mr. Nathanielsz is employed by the Company and subject to the other provisions of the Employment Agreement. The Initial Nathanielsz RSUs shall vest on the one-year anniversary of the Effective Date, subject to Mr. Nathanielsz’s continued employment with the Company through such vesting date. The Additional Nathanielsz RSUs will vest as follows, subject to Mr. Nathanielsz’s continued employment with the Company through the applicable vesting date: (i) 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company submitting Clinical Trial Application (the “CTA”) for PRP, the Company’s lead product candidate (“PRP”), for a First-In-Human study for PRP (the “Study”) in an applicable jurisdiction to be selected by the Company, (ii) 7.80 of the Additional Nathanielsz RSUs shall vest upon the CTA being approved in an applicable jurisdiction, (iii) 7.80 of the Additional RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iv) 7.80 of the Additional Nathanielsz RSUs shall vest upon the shares of the Company’s Common Stock being listed on a senior stock exchange (NYSE, NYSEMKT or NASDAQ), and (v) the remaining 7.80 of the Additional Nathanielsz RSUs shall vest upon the Company enrolling its first patient in the Study. | |||||||||||||||||||||||||||||||
| Option term | 10 years | 10 years | |||||||||||||||||||||||||||||||
| Dr. Kenyon [Member] | Services Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Agreement term | 3 years | 3 years | |||||||||||||||||||||||||||||||
| Agreement renewal term | 1 year | 1 year | |||||||||||||||||||||||||||||||
| Option purchase shares | 20 | 20 | |||||||||||||||||||||||||||||||
| Exercise price | $ / shares | $ 4,250 | ||||||||||||||||||||||||||||||||
| Market price | 100.00% | 100.00% | |||||||||||||||||||||||||||||||
| Options vested, description | The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon’s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon’s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) | The Kenyon Options have a term of 10 years from the date of grant. 1/3rd of the Kenyon Options shall vest every successive one-year anniversary following the Effective Date, provided, that on each such vesting date Dr. Kenyon is employed by the Company and subject to the other provisions of the Services Agreement. The Initial Kenyon RSUs shall vest on the one-year anniversary of the Effective Date, subject to Dr. Kenyon’s continued employment with the Company through such vesting date. The Additional Kenyon RSUs will vest as follows, subject to Dr. Kenyon’s continued employment with the Company through the applicable vesting date: (i) 5 of the Additional Kenyon RSUs shall vest upon the Company submitting the CTA for PRP for the Study in an applicable jurisdiction to be selected by the Company, (ii) 5 of the Additional Kenyon RSUs shall vest upon the Company completing an equity financing in the amount of at least $4,000,000 in gross proceeds, (iii) | |||||||||||||||||||||||||||||||
| Option term | 10 years | 10 years | |||||||||||||||||||||||||||||||
| Dr. Kenyon [Member] | Cancellation Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Debt conversion, converted instrument, shares issued | 3,420,000 | ||||||||||||||||||||||||||||||||
| Cancellation of accrued salary | $ | $ 102,600 | ||||||||||||||||||||||||||||||||
| Dr Kenyon [Member] | Services Agreement [Member] | |||||||||||||||||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||||||||||||||||
| Annual salary | $ | $ 54,000 | ||||||||||||||||||||||||||||||||